8-K: Waters Corporation Reports Mixed Q1 2024 Results, Maintains Full-Year Guidance

Waters Corporation's first quarter 2024 sales declined by 7% as reported, but the company maintained its full-year guidance, citing strong operational performance.

Summary

• Waters Corporation announced its first quarter 2024 financial results, with sales of $637 million, a 7% decrease compared to the same period last year.
• The company's sales were at the high end of their guidance, despite a 9% decline in organic constant currency.
• GAAP earnings per share (EPS) was $1.72, while non-GAAP EPS was $2.21, both down from the previous year but above guidance.
• The company experienced a 4% headwind due to unfavorable foreign exchange rates.
• Gross margin expanded by 40 basis points and adjusted operating margin expanded by 20 basis points due to operational excellence.
• Operating cash flow was strong at $263 million, with free cash flow at $234 million, representing 37% of sales.
• Full-year guidance for organic constant currency sales growth is maintained at -0.5% to +1.5%, and non-GAAP EPS is expected to be between $11.75 and $12.05.
• Second quarter 2024 organic constant currency sales growth is expected to be between -6.0% and -4.0%, with non-GAAP EPS between $2.50 and $2.60.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company exceeded guidance for EPS and maintained full-year guidance, the significant sales decline and year-over-year decrease in earnings are concerning. The company is facing headwinds from foreign exchange and market conditions, but is also showing some operational improvements.

Positives

• The company's sales were at the high end of their guidance for the quarter.
• Both GAAP and non-GAAP EPS exceeded guidance.
• Gross and adjusted operating margins expanded due to operational excellence.
• The company generated strong operating and free cash flow.
• Full-year guidance was maintained despite a challenging first quarter.
• Recurring revenues increased by 3% as reported and in organic constant currency.

Negatives

• Sales declined by 7% as reported and 9% in organic constant currency compared to the same quarter last year.
• GAAP EPS decreased from $2.38 to $1.72 year-over-year.
• Non-GAAP EPS decreased from $2.49 to $2.21 year-over-year.
• The company experienced a 4% headwind due to unfavorable foreign exchange rates.
• Instrument system sales decreased significantly by 20% as reported and 25% in organic constant currency.
• Sales in Asia decreased by 18% as reported and 16% in organic constant currency.
• Sales in the academic and government market decreased by 25% as reported and 30% in organic constant currency.

Risks

• The company faces risks related to foreign currency exchange rate fluctuations, which negatively impacted results this quarter.
• Global economic and political uncertainties, including the ongoing conflicts in Ukraine and the Middle East, could affect the company's performance.
• The Chinese government's tightening restrictions on procurement by government-funded customers pose a risk.
• The company's ability to access capital and service its debt in volatile market conditions is a concern.
• Changes in demand for the company's products and the introduction of competing products could impact sales and market share.
• The company faces risks associated with cybersecurity and technology, including potential breaches.
• Regulatory changes and increased burdens could affect the company's operations and profitability.

Future Outlook

The company maintains its full-year 2024 organic constant currency sales growth guidance at -0.5% to +1.5% and non-GAAP EPS guidance at $11.75 to $12.05. Second quarter 2024 organic constant currency sales growth is expected to be between -6.0% and -4.0%, with non-GAAP EPS between $2.50 and $2.60.

Management Comments

• Dr. Udit Batra, President & CEO, stated that first quarter revenues were at the high end of guidance and the team continues to execute well.
• Dr. Batra also noted that the margin expansion reflects the strength of operational performance, especially considering current volume and foreign exchange headwinds.
• Dr. Batra mentioned that the company is well-positioned in attractive end-markets with a steady stream of innovative new products and a focus on higher growth areas.

Industry Context

Waters Corporation operates in the analytical instruments and software industry, serving the life, materials, food, and environmental sciences. The results reflect a mixed performance in a challenging economic environment, with some sectors and geographies experiencing significant declines while others showed resilience. The company's focus on recurring revenue streams and operational efficiency is a common strategy in this industry to mitigate the impact of economic fluctuations.

Comparison to Industry Standards

• Waters' 7% decline in reported sales is worse than some of its competitors in the analytical instruments space, such as Agilent Technologies, which reported a more modest decline in their most recent quarter.
• The 9% organic constant currency decline is also a concern, as many competitors are showing flat or positive growth in this metric.
• However, Waters' margin expansion is a positive sign, as many companies are struggling with profitability in the current environment. Companies like Thermo Fisher Scientific have also focused on operational efficiency to maintain margins.
• The 37% free cash flow as a percentage of sales is a strong result, indicating good cash management, which is comparable to other well-managed companies in the sector.
• The maintained full-year guidance is a positive signal, but the second quarter guidance indicates continued challenges, which is similar to the outlook provided by other companies in the industry.

Stakeholder Impact

• Shareholders may be concerned about the sales decline and year-over-year decrease in earnings.
• Employees may be affected by cost-saving initiatives and workforce reductions.
• Customers may experience changes in product availability or pricing.
• Suppliers may be impacted by changes in the company's purchasing patterns.
• Creditors may be concerned about the company's ability to service its debt.

Next Steps

• The company will continue to focus on operational excellence and cost-saving initiatives.
• They will also focus on new product development and higher growth areas.
• The company will monitor market conditions and adjust strategies as needed.
• The company will host a conference call to discuss the results.

Key Dates

Keywords

financial results, earnings, sales, organic growth, constant currency, EPS, cash flow, guidance, margins, instruments, recurring revenue, pharmaceutical, industrial, academic, government